1. Home
  2. QLGN vs ASTI Comparison

QLGN vs ASTI Comparison

Compare QLGN & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • ASTI
  • Stock Information
  • Founded
  • QLGN 1996
  • ASTI 2005
  • Country
  • QLGN United States
  • ASTI United States
  • Employees
  • QLGN N/A
  • ASTI N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • QLGN Health Care
  • ASTI Technology
  • Exchange
  • QLGN Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • QLGN 3.4M
  • ASTI 2.8M
  • IPO Year
  • QLGN N/A
  • ASTI N/A
  • Fundamental
  • Price
  • QLGN $4.18
  • ASTI $2.86
  • Analyst Decision
  • QLGN
  • ASTI
  • Analyst Count
  • QLGN 0
  • ASTI 0
  • Target Price
  • QLGN N/A
  • ASTI N/A
  • AVG Volume (30 Days)
  • QLGN 54.9K
  • ASTI 55.4K
  • Earning Date
  • QLGN 11-14-2024
  • ASTI 11-14-2024
  • Dividend Yield
  • QLGN N/A
  • ASTI N/A
  • EPS Growth
  • QLGN N/A
  • ASTI N/A
  • EPS
  • QLGN N/A
  • ASTI N/A
  • Revenue
  • QLGN N/A
  • ASTI $44,673.00
  • Revenue This Year
  • QLGN N/A
  • ASTI N/A
  • Revenue Next Year
  • QLGN N/A
  • ASTI N/A
  • P/E Ratio
  • QLGN N/A
  • ASTI N/A
  • Revenue Growth
  • QLGN N/A
  • ASTI N/A
  • 52 Week Low
  • QLGN $3.34
  • ASTI $2.25
  • 52 Week High
  • QLGN $30.50
  • ASTI $102.00
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 43.01
  • ASTI 57.20
  • Support Level
  • QLGN $3.53
  • ASTI $2.47
  • Resistance Level
  • QLGN $4.39
  • ASTI $3.15
  • Average True Range (ATR)
  • QLGN 0.33
  • ASTI 0.24
  • MACD
  • QLGN 0.06
  • ASTI 0.06
  • Stochastic Oscillator
  • QLGN 50.98
  • ASTI 69.82

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: